Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 1
1975 1
1977 1
1982 1
1983 2
1984 2
1985 2
1986 3
1987 6
1988 7
1989 2
1991 6
1992 1
1993 12
1994 8
1995 1
1996 2
1997 4
1998 8
1999 3
2000 4
2001 5
2002 8
2003 3
2004 2
2005 2
2006 5
2007 9
2008 7
2009 10
2010 8
2011 9
2012 7
2013 7
2014 7
2015 6
2016 8
2017 5
2018 3
2019 9
2020 6
2021 10
2022 7
2023 3
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H. Okuno Y, et al. Among authors: kikuta a. Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21. Nat Microbiol. 2019. PMID: 30664667
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.
Miyagawa N, Goto H, Ogawa A, Kikuta A, Kosaka Y, Sekimizu M, Tomizawa D, Toyoda H, Hiramatsu H, Hara J, Mochizuki S, Nakayama H, Yoshimura K, Iijima-Yamashita Y, Sanada M, Ogawa C. Miyagawa N, et al. Among authors: kikuta a. Int J Hematol. 2023 Aug;118(2):267-276. doi: 10.1007/s12185-023-03609-8. Epub 2023 May 1. Int J Hematol. 2023. PMID: 37127801 Clinical Trial.
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.
Ogawa A, Kawamoto H, Hara J, Kikuta A, Ogawa C, Hiraga H, Yoshimura K, Miyairi K, Omori R, Ro T, Kamei Y, Kimura T. Ogawa A, et al. Among authors: kikuta a. Cancer Chemother Pharmacol. 2024 Jul;94(1):89-101. doi: 10.1007/s00280-024-04664-6. Epub 2024 Mar 13. Cancer Chemother Pharmacol. 2024. PMID: 38478074 Free PMC article. Clinical Trial.
212 results